Quest Partners LLC Replimune Group, Inc. Transaction History
Quest Partners LLC
- $753 Billion
- Q4 2024
A detailed history of Quest Partners LLC transactions in Replimune Group, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 6,404 shares of REPL stock, worth $89,848. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,404
Previous 13,496
52.55%
Holding current value
$89,848
Previous $148 Million
47.57%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding REPL
# of Institutions
160Shares Held
74.9MCall Options Held
38.4KPut Options Held
43.7K-
Baker Bros. Advisors LP New York, NY11MShares$155 Million1.48% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$154 Million0.02% of portfolio
-
Redmile Group, LLC San Francisco, CA4.91MShares$68.8 Million4.65% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$66.1 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.97MShares$55.7 Million8.12% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $692M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...